Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes*-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes*

Published:2012-08-09 Issue:4 Volume:61 Page:629-643
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Di Palma Silvana,Simpson Roderick H W,Marchiò Caterina,Skálová Alena,Ungari Marco,Sandison Ann,Whitaker Stephen,Parry Suzanne,Reis-Filho Jorge S

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2012.04252.x/fullpdf

Reference74 articles.

1. Speichelgangcarcinom: ein den milchgangcarcinomen der brüstdruse analoge gruppe von speicheldrüsentumoren (Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma);Kleinsasser;Archiv. Klin. Exp. Ohren Nasen Kehlkopfheilkunde,1968

2. Histological Typing of Salivary Gland Tumours

3. Selected recent advances in the pathology of salivary neoplasms;Simpson;Diagn. Histopathol.,2010

4. Intraoral salivary duct carcinoma: a report of 5 cases;van Heerden;J. Oral Maxillofac. Surg.,2003

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-grade salivary carcinomas: A current insight on diagnostic pathology and the key to clinical decision making;Seminars in Diagnostic Pathology;2024-07

2. Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases;Histopathology;2024-06-03

3. Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies;International Journal of Molecular Sciences;2024-02-23

4. HER2-targeted therapies for salivary gland cancers;Oral Oncology;2024-01

5. ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy;Modern Pathology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3